Search PDMR transactions

Notifier
Name of person with notification obligation
Kerstin Hasselgren
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Kerstin Hasselgren
Position
Chief Financial Officer (CFO)
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
XSpray Pharma AB (publ)
Issuer´s LEI code
549300NGRQCNZ3X4L157
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Subcription warrant Xspray Pharma AB TO5 SE0020353548 Exercise decrease 916 Quantity 40.00 SEK 04/12/2023 NASDAQ STOCKHOLM AB
Share XSpray Pharma AB SE0009973563 Exercise increase 916 Quantity 40.00 SEK 04/12/2023 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Xspray Pharma AB TO5 SE0020353548 Exercise decrease 04/12/2023 NASDAQ STOCKHOLM AB 916 (Quantity) 40.00 SEK
XSpray Pharma AB SE0009973563 Exercise increase 04/12/2023 NASDAQ STOCKHOLM AB 916 (Quantity) 40.00 SEK
<< Back